Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFSW
2601
DELISTED
PFSweb, Inc.
PFSW
| $1.15M | ﹤0.01% |
131,279
-8,071
| -6% | -$61.8K |
|
|
AWF
2602
AllianceBernstein Global High Income Fund
AWF
$878M
| $1.15M | ﹤0.01% |
+96,412
| New | +$1.18M |
|
2603
PUT
Cooper Companies
COO
$14.2B
| $1.14M | ﹤0.01% |
+20,000
| New | +$1.17M |
|
2604
Donegal Group Class A
DGICA
$710M
| $1.14M | ﹤0.01% |
72,428
-53,270
| -42% | -$875K |
|
2605
Gartner
IT
$12.4B
| $1.14M | ﹤0.01% |
9,714
+2,441
| +34% | +$305K |
|
2606
Altisource Portfolio Solutions
ASPS
$62.7M
| $1.14M | ﹤0.01% |
5,354
+4,025
| +303% | +$892K |
|
|
GNTY
2607
DELISTED
Guaranty Bancshares
GNTY
| $1.13M | ﹤0.01% |
37,433
-921
| -2% | -$27.3K |
|
|
CTLT
2608
DELISTED
CATALENT, INC.
CTLT
| $1.13M | ﹤0.01% |
27,629
-515,441
| -95% | -$21.9M |
|
2609
Gold Fields
GFI
$43.7B
| $1.13M | ﹤0.01% |
+281,436
| New | +$1.15M |
|
2610
Harvard Bioscience
HBIO
$34.5M
| $1.13M | ﹤0.01% |
22,562
+20,416
| +951% | +$915K |
|
2611
CALL
General Mills
GIS
$21.3B
| $1.13M | ﹤0.01% |
25,000
-275,000
| -92% | -$14.9M |
|
|
WW
2612
DELISTED
WW International
WW
| $1.13M | ﹤0.01% |
17,684
-126,195
| -88% | -$8.09M |
|
2613
Accuray
ARAY
$31.8M
| $1.12M | ﹤0.01% |
224,882
-2,685,640
| -92% | -$14.1M |
|
2614
Fennec Pharmaceuticals
FENC
$411M
| $1.12M | ﹤0.01% |
+92,658
| New | +$875K |
|
2615
Myriad Genetics
MYGN
$305M
| $1.12M | ﹤0.01% |
37,852
-196,624
| -84% | -$6.65M |
|
|
TRHC
2616
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.12M | ﹤0.01% |
28,778
+19,178
| +200% | +$672K |
|
|
ICD
2617
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.11M | ﹤0.01% |
14,728
+5,376
| +57% | +$472K |
|
2618
Vitamin Cottage Natural Grocers
NGVC
$651M
| $1.11M | ﹤0.01% |
154,891
+33,178
| +27% | +$254K |
|
2619
PUT
Qualcomm
QCOM
$169B
| $1.11M | ﹤0.01% |
+20,000
| New | +$1.27M |
|
2620
Vail Resorts
MTN
$5.27B
| $1.11M | ﹤0.01% |
4,994
-137,144
| -96% | -$30M |
|
2621
Mustang Bio
MBIO
$4.18M
| $1.1M | ﹤0.01% |
135
+99
| +275% | +$843K |
|
2622
Central Garden & Pet Co
CENT
$2.77B
| $1.1M | ﹤0.01% |
32,089
-226,871
| -88% | -$7.16M |
|
|
MARK
2623
DELISTED
Remark Holdings, Inc.
MARK
| $1.1M | ﹤0.01% |
19,436
+11,280
| +138% | +$1.04M |
|
|
ERN
2624
DELISTED
Erin Energy Corp
ERN
| $1.1M | ﹤0.01% |
302,374
+155,637
| +106% | +$524K |
|
|
IGD
2625
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$521M
| $1.1M | ﹤0.01% |
150,571
+117,621
| +357% | +$897K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.